Lab Reagents
Human IgG antibody Laboratories manufactures the sars cov igg antibody cpl reagents distributed by Genprice. The Sars Cov Igg Antibody Cpl reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars products are available in stock. Specificity: Sars Category: Cov Group: Igg Antibody
Igg Antibody information
SARS CoV E Protein |
|
abx060650-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
|
SARS CoV Nucleocapsid Protein |
|
abx060652-1mg |
Abbexa |
1 mg |
EUR 2247.6 |
|
|
SARS-CoV Nucleocapsid Protein |
|
abx060653-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
|
SARS-CoV Nucleocapsid Protein |
|
abx060654-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
|
SARS-CoV Spike Protein |
|
abx060655-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
|
SARS-CoV-2 IgG ELISA Kit 1-plate EUA |
|
K075-H1 |
Arbor Assays |
1-plate |
EUR 662.4 |
|
Description: This K075-H1 SARS-CoV-2 IgG ELISA Kit 1-plate EUA is only for certified clinical lab use only. The assay has been submitted for Emergency Use Authorization (EUA) through the US FDA. It has not been approved at the current time. |
SARS-CoV-2 IgG ELISA Kit 5-plate EUA |
|
K075-H5 |
Arbor Assays |
5-plate |
EUR 2464.8 |
|
Description: This K075-H5 SARS-CoV-2 IgG ELISA Kit 5-plate EUA is only for certified clinical lab use only. The assay has been submitted for Emergency Use Authorization (EUA) through the US FDA. It has not been approved at the current time. |
Anti-CoV-2 & SARS-CoV S1 Antibody (Clone# CR3022) |
|
A2103-200 |
Biovision |
200 µg |
EUR 576 |
SARS-CoV Nucleocapsid Recombinant Protein |
|
11-173 |
ProSci |
0.1 mg |
EUR 752.1 |
|
Description: Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool. |
SARS-CoV-2 Spike Peptide |
|
9083P |
ProSci |
0.05 mg |
EUR 235.5 |
|
Description: (NT) SARS-CoV-2 Spike peptide |
SARS-CoV-2 Spike Peptide |
|
9087P |
ProSci |
0.05 mg |
EUR 235.5 |
|
Description: (CT) SARS-CoV-2 Spike RBD peptide |
SARS-CoV-2 Spike Peptide |
|
9091P |
ProSci |
0.05 mg |
EUR 235.5 |
|
Description: (IN) SARS-CoV-2 Spike peptide |
SARS-CoV-2 Spike Peptide |
|
9095P |
ProSci |
0.05 mg |
EUR 235.5 |
|
Description: (IN) SARS-CoV-2 Spike peptide |
SARS-CoV-2 Nucleocapsid Peptide |
|
9099P |
ProSci |
0.05 mg |
EUR 235.5 |
|
Description: (IN) SARS-CoV-2 Nucleocapsid peptide |
SARS-CoV-2 Nucleocapsid Peptide |
|
9103P |
ProSci |
0.05 mg |
EUR 235.5 |
|
Description: (CT) SARS-CoV-2 Nucleocapsid peptide |
Recombinant Coronavirus Nucleoprotein (SARS-CoV) |
|
P1509-10 |
Biovision |
10µg |
EUR 661.2 |
